Myralis Pharma

myralis.com.br

Total dedication to life Innovative and modern in the pharmaceutical sector, the goal to be achieved is in line with what we propose to our clients and partners: always look forward. The reason? The health of thousands of people. Pioneering, Excellence and Technology in our Brands of Success. With a highly qualified Research and Development team, we are able to work together with our physicians, launching pioneering brands in the market. Our growth gives us the certainty of the path and enthusiasm to move forward. That is why we have evolved at a fast and constant pace, delivering innovative medicines not only for our own line but also for a network of partners.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

TREATMENT TO EXPAND GLOBAL LIBRARY OF MEDICINE WITH DERMATOLOGIC DISEASES

Treatment.com International Inc. | January 05, 2022

news image

Treatment.com International Inc. a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to the GLM, enhancing soon-to-be-released products such as the Treatment Mobile app, which is set for release this month.
Read More

Pharmacy Market

PALATIN ANNOUNCES DIRECT-TO-CONSUMER TELEHEALTH PARTNERSHIP WITH UPSCRIPTHEALTH™ FOR VYLEESI®

PRNewswire | August 08, 2023

news image

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that it has entered a strategic partnership with UpScriptHealth, a leading direct-to-consumer telemedicine company providing telemedicine services to pharmaceutical and medical technology companies. Under terms of the agreement, UpScriptHealth will make Vyleesi available to the hundreds of thousands of ...

Read More

JAZZ PHARMACEUTICALS ANNOUNCES NEW RESEARCH COLLABORATION WITH REDX PHARMA TO DISCOVER AND DEVELOP TWO TARGETED CANCER THERAPIES

Jazz Pharmaceuticals | September 09, 2020

news image

Jazz Pharmaceuticals plc today announced that the company has signed a new research collaboration agreement with Redx Pharma plc (AIM: REDX) to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase (MAPK) pathway. This research collaboration follows the previously announced sale of Redx's pre-clinical pan-RAF inhibitor program to Jazz for the potential treatment of Raf and Ras mutant tumors in July 2019. Under the terms of the research collaboration agre...

Read More

Business Insights, PHARMA TECH

ELLIGO INTRODUCES AI-DRIVEN CLINICAL RESEARCH STUDY TECHNOLOGY TO EXPEDITE TRIALS

Elligo Health Research | January 25, 2023

news image

On January 24, 2023, Elligo Health Research®, the leading healthcare-enabling research organization, presented the DataAI Connect, a new data and technology platform that will facilitate data-driven, rapid clinical research. DataAI Connect, a scalable, end-to-end data platform, optimizes the clinical research workflow by decreasing human error and rapidly digesting patient data to speed up clinical studies. Elligo has created an industry-first AI-driven platform that sources...

Read More
news image

Business Insights

TREATMENT TO EXPAND GLOBAL LIBRARY OF MEDICINE WITH DERMATOLOGIC DISEASES

Treatment.com International Inc. | January 05, 2022

Treatment.com International Inc. a healthcare AI technology company, has entered into a research project agreement with the University of Minnesota to add more than 220 dermatologic diseases to their proprietary, responsive AI engine known as the Global Library of Medicine (GLM). The addition of these diagnoses will bring another level of accuracy and specificity to the GLM, enhancing soon-to-be-released products such as the Treatment Mobile app, which is set for release this month.
Read More

news image

Pharmacy Market

PALATIN ANNOUNCES DIRECT-TO-CONSUMER TELEHEALTH PARTNERSHIP WITH UPSCRIPTHEALTH™ FOR VYLEESI®

PRNewswire | August 08, 2023

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that it has entered a strategic partnership with UpScriptHealth, a leading direct-to-consumer telemedicine company providing telemedicine services to pharmaceutical and medical technology companies. Under terms of the agreement, UpScriptHealth will make Vyleesi available to the hundreds of thousands of ...

Read More
news image

JAZZ PHARMACEUTICALS ANNOUNCES NEW RESEARCH COLLABORATION WITH REDX PHARMA TO DISCOVER AND DEVELOP TWO TARGETED CANCER THERAPIES

Jazz Pharmaceuticals | September 09, 2020

Jazz Pharmaceuticals plc today announced that the company has signed a new research collaboration agreement with Redx Pharma plc (AIM: REDX) to discover and develop drug candidates for two cancer targets in the Ras/Raf/MAP kinase (MAPK) pathway. This research collaboration follows the previously announced sale of Redx's pre-clinical pan-RAF inhibitor program to Jazz for the potential treatment of Raf and Ras mutant tumors in July 2019. Under the terms of the research collaboration agre...

Read More
news image

Business Insights, PHARMA TECH

ELLIGO INTRODUCES AI-DRIVEN CLINICAL RESEARCH STUDY TECHNOLOGY TO EXPEDITE TRIALS

Elligo Health Research | January 25, 2023

On January 24, 2023, Elligo Health Research®, the leading healthcare-enabling research organization, presented the DataAI Connect, a new data and technology platform that will facilitate data-driven, rapid clinical research. DataAI Connect, a scalable, end-to-end data platform, optimizes the clinical research workflow by decreasing human error and rapidly digesting patient data to speed up clinical studies. Elligo has created an industry-first AI-driven platform that sources...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us